Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 172

1.

Involvement of Flt-1 tyrosine kinase (vascular endothelial growth factor receptor-1) in pathological angiogenesis.

Hiratsuka S, Maru Y, Okada A, Seiki M, Noda T, Shibuya M.

Cancer Res. 2001 Feb 1;61(3):1207-13.

2.

Expression of vascular endothelial growth factor, placental growth factor, and their receptors Flt-1 and KDR in human placenta under pathologic conditions.

Kumazaki K, Nakayama M, Suehara N, Wada Y.

Hum Pathol. 2002 Nov;33(11):1069-77. Erratum in: Hum Pathol 2002 Dec;33(12):1244.

PMID:
12454810
3.

Antiangiogenic effect by SU5416 is partly attributable to inhibition of Flt-1 receptor signaling.

Itokawa T, Nokihara H, Nishioka Y, Sone S, Iwamoto Y, Yamada Y, Cherrington J, McMahon G, Shibuya M, Kuwano M, Ono M.

Mol Cancer Ther. 2002 Mar;1(5):295-302.

5.

Flt-1 but not KDR/Flk-1 tyrosine kinase is a receptor for placenta growth factor, which is related to vascular endothelial growth factor.

Sawano A, Takahashi T, Yamaguchi S, Aonuma M, Shibuya M.

Cell Growth Differ. 1996 Feb;7(2):213-21.

6.

Possible involvement of VEGF-FLT tyrosine kinase receptor system in normal and tumor angiogenesis.

Shibuya M, Seetharam L, Ishii Y, Sawano A, Gotoh N, Matsushime H, Yamaguchi S.

Princess Takamatsu Symp. 1994;24:162-70. Review.

PMID:
8983073
7.
8.

Design of a variant of vascular endothelial growth factor-A (VEGF-A) antagonizing KDR/Flk-1 and Flt-1.

Leenders W, Lubsen N, van Altena M, Clauss M, Deckers M, Löwik C, Breier G, Ruiter D, de Waal R.

Lab Invest. 2002 Apr;82(4):473-81.

PMID:
11950904
9.

Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma.

Boocock CA, Charnock-Jones DS, Sharkey AM, McLaren J, Barker PJ, Wright KA, Twentyman PR, Smith SK.

J Natl Cancer Inst. 1995 Apr 5;87(7):506-16.

PMID:
7707437
10.
11.

Gene expression of VEGF and its receptors Flk-1/KDR and Flt-1 in cultured and transplanted rat islets.

Vasir B, Jonas JC, Steil GM, Hollister-Lock J, Hasenkamp W, Sharma A, Bonner-Weir S, Weir GC.

Transplantation. 2001 Apr 15;71(7):924-35.

PMID:
11349728
14.

A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF.

Seetharam L, Gotoh N, Maru Y, Neufeld G, Yamaguchi S, Shibuya M.

Oncogene. 1995 Jan 5;10(1):135-47.

PMID:
7824266
15.

Identification of receptor genes in renal cell carcinoma associated with angiogenesis by differential hybridization technique.

Takahashi A, Sasaki H, Kim SJ, Kakizoe T, Miyao N, Sugimura T, Terada M, Tsukamoto T.

Biochem Biophys Res Commun. 1999 Apr 21;257(3):855-9.

PMID:
10208873
16.
17.

[Expression of vascular endothelial growth factor and its receptors in endometrial carcinoma].

Wang H, Chen G, Zhang B.

Zhonghua Bing Li Xue Za Zhi. 2002 Oct;31(5):391-5. Chinese.

PMID:
12485477
18.

Neovascularization in human germ cell tumors correlates with a marked increase in the expression of the vascular endothelial growth factor but not the placenta-derived growth factor.

Viglietto G, Romano A, Maglione D, Rambaldi M, Paoletti I, Lago CT, Califano D, Monaco C, Mineo A, Santelli G, Manzo G, Botti G, Chiappetta G, Persico MG.

Oncogene. 1996 Aug 1;13(3):577-87.

PMID:
8760299
20.

KDR/Flk-1 is a major regulator of vascular endothelial growth factor-induced tumor development and angiogenesis in murine hepatocellular carcinoma cells.

Yoshiji H, Kuriyama S, Hicklin DJ, Huber J, Yoshii J, Miyamoto Y, Kawata M, Ikenaka Y, Nakatani T, Tsujinoue H, Fukui H.

Hepatology. 1999 Nov;30(5):1179-86.

PMID:
10534339

Supplemental Content

Support Center